{
    "title": "Unveiling Molecular Moieties through Hierarchical Graph Explainability",
    "abstract": "Background: Graph Neural Networks (GNN) have emerged in very recent years as a powerful tool for supporting in silico Virtual Screening. In this work we present a GNN which uses Graph Convolutional architectures to achieve very accurate multi-target screening. We also devised a hierarchical Explainable Artificial Intelligence (XAI) technique to catch information directly at atom, ring, and whole molecule level by leveraging the message passing mechanism. In this way, we find the most relevant moieties involved in bioactivity prediction. Results: We report a state-of-the-art GNN classifier on twenty Cyclin-dependent Kinase targets in support of VS. Our classifier outperforms previous SOTA approaches proposed by the authors. Moreover, a CDK1-only high-sensitivity version of the GNN has been designed to use our explainer in order to avoid the inherent bias of multi-class models. The hierarchical explainer has been validated by an expert chemist on 19 approved drugs on CDK1. Our explainer ",
    "link": "https://arxiv.org/abs/2402.01744",
    "context": "Title: Unveiling Molecular Moieties through Hierarchical Graph Explainability\nAbstract: Background: Graph Neural Networks (GNN) have emerged in very recent years as a powerful tool for supporting in silico Virtual Screening. In this work we present a GNN which uses Graph Convolutional architectures to achieve very accurate multi-target screening. We also devised a hierarchical Explainable Artificial Intelligence (XAI) technique to catch information directly at atom, ring, and whole molecule level by leveraging the message passing mechanism. In this way, we find the most relevant moieties involved in bioactivity prediction. Results: We report a state-of-the-art GNN classifier on twenty Cyclin-dependent Kinase targets in support of VS. Our classifier outperforms previous SOTA approaches proposed by the authors. Moreover, a CDK1-only high-sensitivity version of the GNN has been designed to use our explainer in order to avoid the inherent bias of multi-class models. The hierarchical explainer has been validated by an expert chemist on 19 approved drugs on CDK1. Our explainer ",
    "path": "papers/24/02/2402.01744.json",
    "total_tokens": 872,
    "translated_title": "通过分层图解释揭示分子成分",
    "translated_abstract": "背景：图神经网络（GNN）作为一种强大的工具，在支持体外虚拟筛选方面已经出现多年。在这项工作中，我们提出了一种使用图卷积架构实现高精度多靶标筛选的GNN。我们还设计了一种分层可解释人工智能（XAI）技术，通过利用信息传递机制，在原子、环和整个分子层面上直接捕获信息，从而找到与生物活性预测相关的最重要的成分。结果：我们在支持虚拟筛选方面的二十个细胞周期依赖性激酶靶标上报道了一种最先进的GNN分类器。我们的分类器超越了作者提出的先前最先进方法。此外，我们还设计了一个仅针对CDK1的高灵敏度版本的GNN，以使用我们的解释器来避免多类别模型固有的偏差。分层解释器已经由一位专家化学家在19个CDK1批准药物上进行了验证。",
    "tldr": "本论文提出了一种使用图神经网络和分层可解释人工智能技术的方法，能够准确预测生物活性并找到与之相关的最重要的成分。",
    "en_tdlr": "This paper presents a method that combines Graph Neural Networks and hierarchical Explainable Artificial Intelligence techniques to accurately predict bioactivity and identify the most relevant molecular moieties."
}